Top Markets
Coin of the day
The Greater Cannabis Company, Inc. The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc.

GCAN
株式のランク #40153
The Greater Cannabis Company, Inc. engages in the development and... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
株価
$0.2301
最終同期: 2026-08-12
時価総額
$228.81K
変化(1日)
-17.82%
変化(1年)
95,775.00%
US
取引 The Greater Cannabis Company, Inc. (GCAN)

カテゴリー

The Greater Cannabis Company, Inc.(GCAN)のEPS
2026 時点のEPS TTM: 0
The Greater Cannabis Company, Inc.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
The Greater Cannabis Company, Inc.のEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS